NexGenEsis Healthcare - Columbus

NexGenEsis Healthcare in Columbus, OH, operates under the clinical direction of Dr. Vidya Sundaram, MD, delivering regenerative medicine protocols that prioritize non-surgical interventions for musculoskeletal conditions and peripheral neuropathy. The practice integrates peptide therapy, platelet-rich plasma applications, and targeted biologic treatments to address chronic joint deterioration, nerve damage, and mobility limitations that have not responded adequately to conventional pain management. Dr. Sundaram's approach centers on identifying the underlying inflammatory and degenerative processes contributing to each patient's symptoms, then designing treatment plans that combine regenerative modalities with functional rehabilitation strategies.

The clinic's peptide therapy menu includes BPC-157 for tendon and ligament repair, TB-500 to accelerate tissue regeneration in injured joints, and thymosin beta-4 for systemic anti-inflammatory effects in patients with widespread musculoskeletal involvement. For neuropathy cases—particularly those affecting the feet and lower extremities—NexGenEsis Healthcare employs a combination of nerve growth factor peptides, vascular optimization protocols, and electrical stimulation therapies designed to restore sensation and reduce burning or tingling symptoms. Joint therapy programs frequently incorporate intra-articular peptide injections alongside hyaluronic acid and autologous growth factors, targeting knees, shoulders, hips, and ankles with degenerative changes visible on imaging studies.

Dr. Sundaram completed her medical degree with subsequent training in integrative and regenerative approaches, allowing her to evaluate patients through both conventional diagnostic frameworks and emerging biologic treatment paradigms. Her clinical methodology involves comprehensive initial consultations that include orthopedic examination, nerve conduction studies when indicated, and detailed review of prior imaging to determine candidacy for regenerative interventions. Patients with failed prior surgeries, those seeking to avoid joint replacement, and individuals with diabetic or idiopathic neuropathy comprise a significant portion of the practice's caseload. Treatment plans are adjusted based on objective measures of pain reduction, functional improvement, and patient-reported outcomes tracked across multiple visits.

In-person consultations at the Columbus office allow Dr. Sundaram to perform hands-on assessments of joint stability, range of motion, and neurological function—critical factors in determining injection sites, peptide selection, and adjunctive therapies. The clinic's neuropathy protocols typically span 8 to 12 weeks, with patients undergoing serial treatments that may include topical compounded medications, nutritional optimization for nerve health, and at-home neurostimulation devices. Joint therapy patients often begin with a loading phase of weekly peptide injections followed by maintenance schedules tailored to activity level and degree of cartilage loss. Follow-up imaging and functional testing help quantify tissue healing and guide decisions about treatment duration or protocol modifications.

NexGenEsis Healthcare's patient population in Columbus includes individuals managing osteoarthritis in weight-bearing joints, athletes with overuse injuries seeking alternatives to corticosteroids, and older adults experiencing progressive neuropathy that limits daily activities. The practice does not offer same-day walk-in services; all regenerative treatments require an initial evaluation to review medical history, current medications, and contraindications such as active malignancy or uncontrolled autoimmune conditions. Dr. Sundaram provides direct oversight of all peptide prescribing and injection procedures, ensuring consistency in technique and dosing. The clinic's focus remains on patients who have exhausted physical therapy and oral medications but wish to delay or avoid surgical intervention, offering a structured pathway from assessment through active treatment and long-term maintenance.